Other Events · Jul 13, 2026IGC Pharma updates investor presentation for July 2026, highlighting IGC-AD1 candidateIGCIGC Pharma, Inc.IGC Pharma, Inc. furnished an updated investor presentation dated July 2026 as part of its Regulation FD disclosure. The company is a biopharmaceutical company focused on developing and commercializing product candidates like IGC-AD1.
